Results 181 to 190 of about 19,421 (203)

Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study

Lancet, The, 2004
Frank Van Leth, Ma Johnson, F Mulcahy
exaly  

Safety of nevirapine in pregnancy

HIV Medicine, 2007
P HAY, A de Ruiter, Graham P Taylor
exaly  

Drug Evaluations Anti-infectives: Nevirapine: A review of its development, pharmacological profile and potential for clinical use

Expert Opinion on Investigational Drugs, 1996
Robert L Murphy
exaly  

Nevirapine toxicity in a cohort of HIV-1–infected pregnant women

American Journal of Obstetrics and Gynecology, 2006
Guilherme Amaral Calvet
exaly  

Nevirapine

Reactions Weekly, 2019
openaire   +2 more sources

Pharmacokinetic study of the interaction between itraconazole and nevirapine

European Journal of Clinical Pharmacology, 2007
Sutep Jaruratanasirikul, Somchai Sriwiriyajan   +1 more
exaly  

Evidence for nevirapine bioactivation in man: Searching for the first step in the mechanism of nevirapine toxicity

Toxicology, 2012
Umbelina Caixàs, Alexandra M M Antunes, Aline T Marinho   +2 more
exaly  

Nevirapine

Reactions Weekly, 2014
openaire   +2 more sources

Population pharmacokinetics of nevirapine in an unselected cohort of HIV-1-infected individuals

British Journal of Clinical Pharmacology, 2002
Monique M R De Maat, Jan W Mulder, Pieter L Meenhorst   +2 more
exaly  

HEPATOTOXICITY FOLLOWING NEVIRAPINE-CONTAINING REGIMENS IN HIV-1-INFECTED INDIVIDUALS

Pharmacological Research, 2002
Monique M R De Maat, Ron A A Mathot, Agnes I Veldkamp   +2 more
exaly